EDGAR Filing Documents for 0001104659-21-110671

Form F-3/A - Registration statement by foreign private issuers: [Amend]

SEC Accession No. 0001104659-21-110671

Filing Date

2021-08-30

Accepted

2021-08-27 19:55:20

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3/A	tm2126411d1_f3a.htm	F-3/A	654303
2	EXHIBIT 23.1	tm2126411d1_ex23-1.htm	EX-23.1	3570
3	GRAPHIC	tm2125310d1_f3img001.jpg	GRAPHIC	14715
	Complete submission text file	0001104659-21-110671.txt		679467

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-3/A | Act: 33 | File No.: 333-258918 | Film No.: 211220610
SIC: 2834 Pharmaceutical Preparations